Carignan, Canada

Michel Cayouette

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Adaerata, Limited Partnership. Active years: 2025-2026.


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.9

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michel Cayouette: Innovator in Neuroscience

Introduction

Michel Cayouette is a prominent inventor based in Carignan, CA. He has made significant contributions to the field of neuroscience, particularly in the development of methods to enhance neuronal health and function. With a total of 2 patents, his work is paving the way for advancements in medical treatments related to neuronal degradation.

Latest Patents

Cayouette's latest patents include groundbreaking research on recombinant nervous system cells and methods to generate them. One notable patent focuses on a method of reducing neuronal microtubule binding protein Tau (Tau) levels. This method promotes neuronal Tau degradation and enhances neuronal survival in subjects in need. The process involves contacting the neurons with an effective amount of an agent that increases the expression and/or activity of a long phosphotyrosine-binding (PTB) Numb isoform. This innovative approach aims to reduce neural Tau levels, thereby promoting neuronal health.

Career Highlights

Throughout his career, Michel Cayouette has been associated with Adaerata, Limited Partnership, where he has been able to apply his expertise in neuroscience. His work has garnered attention for its potential impact on treating neurodegenerative diseases and improving neuronal function.

Collaborations

Cayouette has collaborated with notable colleagues, including Awais Javed and Marine Lacomme. These partnerships have contributed to the advancement of his research and the development of innovative solutions in the field of neuroscience.

Conclusion

Michel Cayouette's contributions to neuroscience through his patents and collaborative efforts highlight his commitment to improving neuronal health. His innovative methods have the potential to significantly impact the treatment of neurodegenerative conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…